More Than Scleroderma
A hub of knowledge, advice and support for those whose lives have been touched by scleroderma.
Search
Congress Patient Benefit
The participation in scientific congresses is firmly established in the event agenda of any pharmaceutical company. But what is happening behind the doors of congress centers? How do patients benefit from the participation of pharmaceutical represent
Taking cancer on with smart combinations
Boehringer Ingelheim digs deep into the science and taking a precision approach to develop smart combinations to bring the greatest benefit to patients.
Three challenges shape future antiparasitic treatment
The three key challenges that will shape the future of antiparasitic treatment
Innovation in medicinal chemistry
Darryl McConnell, Senior Vice President and Research Site Head, Austria and Jürgen Mack, Vice-President, Medicinal Chemistry, explain how we are working to unlock unsolved diseases
A Clear Vision
Take a tour of our journey into Retinal Health through this interactive infographic or descriptive audio recording, and learn how we aim to preserve or restore vision in people with retinal diseases.
A Deep Dive into Wet AMD
Wet AMD is a disease of the central portion of the retina (the macula) which is responsible for high visual acuity that allows for color vision, reading and facial recognition
Geographic Atrophy
Geographic Atrophy is a slowly progressing, yet damaging form of AMD. Approximately 5 million people have Geographic Atrophy worldwide, with disease prevalence increasing with age. It is characterized by regions of cell death in the retina.
Diabetic Retinopathy
Diabetic retinopathy affects 1 in 3 people with diabetes and is the leading cause of vision loss in adults of working age. It is a growing epidemic that is expected to increase as the incidence of diabetes escalates across the globe.
Why today’s depression trials demand smart new approaches
Dr. Vikas Mohan Sharma announces the first of its kind decentralized clinical trial in depression
Grass Roots Events 2022
View our list of Grass Roots events in 2022 and find an event near you.
COVID-19: Research Update
Boehringer Ingelheim stops treatment with experimental medication in study investigating benefits for severely ill patients with COVID-19
Fighting Negative KRAS Feedback
Boehringer Ingelheim scientists are directly targeting KRAS, blocking feedback and ultimately getting ahead of resistance by investigating pan-KRAS approaches. Article from Marco Hofmann
Focus on Alliance Management
Stefan Walke, Global Head of Alliance Management, shares his perspectives on Alliance Management and its contribution to the development of successful long-term partnerships.
Nurjanahs Story
Nurjanah went from a sporty young woman to someone who no longer had the energy to do simple, everyday tasks. She was diagnosed with scleroderma.
Targeting Tumor Stroma
Boehringer Ingelheim’s research approach in stromal biology may lead to new medicines that will change the face of cancer and give new hope to patients
Pioneering Pan-KRAS Research
Boehringer Ingelheim scientists are directly targeting KRAS, blocking feedback and ultimately getting ahead of resistance by investigating pan-KRAS approaches.
Spotlight on GPP
Emmanuelle Clerisme-Beaty, Head of Clinical Development and Medical Affairs, Dermatology, answers some frequently asked questions about GPP.
Press Releases
Press Releases
Press Material
Press Material
Press Kit Animal Health
Press Kit Animal Health
Privacy Notice
Privacy Notice
Human Health Partnering Connect with Us
Human Health Partnering Connect with Us
Human Health Partnering
Human Health Partnering
Human Health Partnering Interests
Human Health Partnering Interests